PDS Biotechnology Corporation (PDSB)

PDS Biotechnology Corporation, a clinical stage immuno-oncology company, develops multifunctional immunotherapeutic products. It develops products to treat early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. The company lead product candidate is PDS0101, an immunotherapeutic for the treatment of cancer. Its synthetic lipid-based immunotherapy platform is Versamune. The company develops Versamune based products for the treatment of cancer. PDS Biotechnology Corporation is based in Berkeley Heights, New Jersey.

Current Quote*
Last: $6.307
Change: 0.007
Book: $1.322
Volume: 10,257

As Of: 06/14 13:21 ET
*Quotes delayed by 20min.

Graphs for PDSB

3 Month Graph

6 Month Graph

1 Year Graph